Polivy 140 MG vials
Ended Awarded
- Contract number
- SPE2DB26FX3MT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,046
Award facts
- Contract value 100% obligated
- $22,046.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Polivy 140 mg vials, a pharmaceutical product used in oncology treatment. This firm fixed price delivery order, valued at $22,046.06, represents a competitive award with no set-aside designation and is scheduled for completion by November 10, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply agreement running through December 2026 that provides global medical commodity support to military healthcare systems worldwide.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains extensive portfolio coverage across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and specialized medical supplies supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's significant presence within the DLA supply chain reflects its demonstrated capability to meet federal procurement requirements through competitive procurement processes, positioning it as a primary supplier for military medical logistics and healthcare support operations.
Quick answers
Who was awarded contract SPE2DB26FX3MT?
SPE2DB26FX3MT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FX3MT worth?
The government has obligated $22,046 on SPE2DB26FX3MT.
Is contract SPE2DB26FX3MT an order under another contract?
Yes. SPE2DB26FX3MT is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX3MT competed?
The extent of competition for SPE2DB26FX3MT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award